FR2689508B1 - Derives de l'imidazole, leur procede de preparation et leur application en therapeutique. - Google Patents

Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.

Info

Publication number
FR2689508B1
FR2689508B1 FR929203944A FR9203944A FR2689508B1 FR 2689508 B1 FR2689508 B1 FR 2689508B1 FR 929203944 A FR929203944 A FR 929203944A FR 9203944 A FR9203944 A FR 9203944A FR 2689508 B1 FR2689508 B1 FR 2689508B1
Authority
FR
France
Prior art keywords
preparation process
therapeutic application
imidazole derivatives
imidazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR929203944A
Other languages
English (en)
Other versions
FR2689508A1 (fr
Inventor
Dodey Pierre
Bondoux Michel
Renaut Patrice
Pruneau Didier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fournier Industrie et Sante SAS
Original Assignee
Fournier Industrie et Sante SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Industrie et Sante SAS filed Critical Fournier Industrie et Sante SAS
Priority to FR929203944A priority Critical patent/FR2689508B1/fr
Priority to TW082102193A priority patent/TW232012B/zh
Priority to AU35546/93A priority patent/AU3554693A/en
Priority to CA002092852A priority patent/CA2092852A1/fr
Priority to FI931414A priority patent/FI931414A/fi
Priority to NO93931186A priority patent/NO931186L/no
Priority to HU9300942A priority patent/HUT64752A/hu
Priority to EP93400833A priority patent/EP0564356A1/fr
Priority to JP5095158A priority patent/JPH06263743A/ja
Priority to KR1019930005246A priority patent/KR930021622A/ko
Priority to CN93104521A priority patent/CN1081438A/zh
Priority to ZA932351A priority patent/ZA932351B/xx
Priority to MX9301882A priority patent/MX9301882A/es
Publication of FR2689508A1 publication Critical patent/FR2689508A1/fr
Application granted granted Critical
Publication of FR2689508B1 publication Critical patent/FR2689508B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/62—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with triarylmethyl radicals attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
FR929203944A 1992-04-01 1992-04-01 Derives de l'imidazole, leur procede de preparation et leur application en therapeutique. Expired - Fee Related FR2689508B1 (fr)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR929203944A FR2689508B1 (fr) 1992-04-01 1992-04-01 Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.
TW082102193A TW232012B (fr) 1992-04-01 1993-03-24
AU35546/93A AU3554693A (en) 1992-04-01 1993-03-29 Imidazole derivatives, their method of preparation and their application in therapeutics
CA002092852A CA2092852A1 (fr) 1992-04-01 1993-03-29 Derives d'imidazole, methode d'obtention et applications therapeutiques
FI931414A FI931414A (fi) 1992-04-01 1993-03-29 Imidazolderivat, foerfarande foer deras framstaellning samt deras anvaendning i terapi
NO93931186A NO931186L (no) 1992-04-01 1993-03-30 Terapeutisk aktive imidazolderivater, fremgangsmaate for deres fremstilling og anvendelse derav
HU9300942A HUT64752A (en) 1992-04-01 1993-03-31 Process for the production of imidazole derivatives and of medical preparatives containing them
EP93400833A EP0564356A1 (fr) 1992-04-01 1993-03-31 Dérivés de 4-phénylaminométhylimidazole, procédé de préparation, antagonistes des récepteurs angiotensin II et leur application en thérapeutique
JP5095158A JPH06263743A (ja) 1992-04-01 1993-03-31 イミダゾール誘導体、その調製方法及び治療への 応用
KR1019930005246A KR930021622A (ko) 1992-04-01 1993-03-31 이미다졸 유도체, 그의 제조방법 및 이 화합물을 함유하는 치료제
CN93104521A CN1081438A (zh) 1992-04-01 1993-04-01 咪唑衍生物及其制备方法和在治疗学上的应用
ZA932351A ZA932351B (en) 1992-04-01 1993-04-01 Imidazole derivatives their method of preparation and their application in therapeutics
MX9301882A MX9301882A (es) 1992-04-01 1993-04-01 Derivados de imidazol, su procedimiento de preparacion y su aplicacion en terapeutica.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR929203944A FR2689508B1 (fr) 1992-04-01 1992-04-01 Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
FR2689508A1 FR2689508A1 (fr) 1993-10-08
FR2689508B1 true FR2689508B1 (fr) 1994-06-17

Family

ID=9428340

Family Applications (1)

Application Number Title Priority Date Filing Date
FR929203944A Expired - Fee Related FR2689508B1 (fr) 1992-04-01 1992-04-01 Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.

Country Status (13)

Country Link
EP (1) EP0564356A1 (fr)
JP (1) JPH06263743A (fr)
KR (1) KR930021622A (fr)
CN (1) CN1081438A (fr)
AU (1) AU3554693A (fr)
CA (1) CA2092852A1 (fr)
FI (1) FI931414A (fr)
FR (1) FR2689508B1 (fr)
HU (1) HUT64752A (fr)
MX (1) MX9301882A (fr)
NO (1) NO931186L (fr)
TW (1) TW232012B (fr)
ZA (1) ZA932351B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015817A (en) * 1996-12-05 2000-01-18 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
UA71587C2 (uk) 1998-11-10 2004-12-15 Шерінг Акцієнгезелльшафт Аміди антранілової кислоти та їхнє застосування як лікарських засобів
DE10023486C1 (de) * 2000-05-09 2002-03-14 Schering Ag Ortho substituierte Anthranilsäureamide und deren Verwendung als Arzneimittel
CA2453396A1 (fr) * 2001-07-11 2003-01-23 Yale University Composes et procedes d'inhibition de trypanosoma cruzi
US7615565B2 (en) 2002-07-31 2009-11-10 Bayer Schering Pharma Aktiengesellschaft VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
UA89035C2 (ru) 2003-12-03 2009-12-25 Лео Фарма А/С Эфиры гидроксамовых кислот и их фармацевтическое применение
EP1655295A1 (fr) 2004-11-03 2006-05-10 Schering Aktiengesellschaft Anthranilamide pyridinurées comme inhibiteurs de kinase du récepteur VEGF
EP1657241A1 (fr) 2004-11-03 2006-05-17 Schering Aktiengesellschaft Nouveaux urées d' anthranylamide pyridine ayant une activité inhibitrice de kinase du récepteur de VEGF
US7906533B2 (en) 2004-11-03 2011-03-15 Bayer Schering Pharma Ag Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
EP1752450A1 (fr) 2005-08-01 2007-02-14 Merck Sante Dérives d'imidazole comme inhibiteurs de la fructose-1,6-bisphosphatase et composés pharmaceutiques les contenant
KR20100031113A (ko) 2007-05-24 2010-03-19 엘드러그 에스.에이. 1,(3),5-치환된 이미다졸, 이의 고혈압 치료 용도 및 이의 제조 방법
GR1006917B (el) * 2007-10-24 2010-07-30 Ελληνικα Φαρμακα Ερευνα Και Αναπτυξη Eldrug Α.Ε., Ανταγωνιστες του υποδοχεα της αγγειοτενσινης ιι με βαση την ισταμινη (και παραγωγα αυτης) με ιδιοτητες καταστολης του συμπαθητικου συστηματος και συνθετικες μεθοδοι στη θεραπεια της υπερτασης και αλλων καρδιοαγγειακων ασθενειων.
EP2188279A2 (fr) * 2007-08-01 2010-05-26 Eldrug S.A. Imidazoles substitués en 1,3 et 1,3,5 comme antihypertensives
TW201010702A (en) 2008-08-27 2010-03-16 Leo Pharma As Novel VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof
CN102584709B (zh) * 2011-12-19 2016-08-17 浙江华海药业股份有限公司 一种改进的依普罗沙坦中间体芳基咪唑醛的制备工艺
JP7197880B2 (ja) * 2017-10-19 2022-12-28 学校法人 名城大学 エステル化剤及びその利用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2110663B (en) * 1981-12-04 1985-08-07 Farmos Group Ltd Imidazole derivatives
CA1334092C (fr) * 1986-07-11 1995-01-24 David John Carini Imidazoles bloquant les recepteurs de l'angiotensine ii
CA1338238C (fr) * 1988-01-07 1996-04-09 David John Carini Imidazoles bloquant les recepteurs de l'angiotensine ii et combinaisons de ces imidazoles avec des diuretiques et des anti-inflammatoires non steroidiens
CA2018443A1 (fr) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Acides imidazolyl-alkenoiques
DE69033469T2 (de) * 1989-06-14 2000-09-07 Smithkline Beecham Corp Imidazoalkensäure
AU640417B2 (en) * 1989-10-25 1993-08-26 Smithkline Beecham Corporation Substituted 5-((tetrazolyl)alkenyl)imidazoles
CA2028925A1 (fr) * 1989-11-06 1991-05-07 Gerald R. Girard Derives substitues de la n-(imidazolyl)alkylalanine
GB8927928D0 (en) * 1989-12-11 1990-02-14 Roussel Lab Ltd Chemical compounds
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,

Also Published As

Publication number Publication date
HUT64752A (en) 1994-02-28
TW232012B (fr) 1994-10-11
EP0564356A1 (fr) 1993-10-06
FI931414A (fi) 1993-10-02
MX9301882A (es) 1994-06-30
FR2689508A1 (fr) 1993-10-08
JPH06263743A (ja) 1994-09-20
CA2092852A1 (fr) 1993-10-02
CN1081438A (zh) 1994-02-02
AU3554693A (en) 1993-10-07
KR930021622A (ko) 1993-11-22
HU9300942D0 (en) 1993-06-28
FI931414A0 (fi) 1993-03-29
NO931186L (no) 1993-10-04
NO931186D0 (no) 1993-03-30
ZA932351B (en) 1994-10-03

Similar Documents

Publication Publication Date Title
FR2487353B1 (fr) Derives d'hydantoine, leur procede de preparation et leur application therapeutique
BE892758A (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
FR2504920B1 (fr) Derives phenylcyclobutyliques, leur procede de preparation et leur application therapeutique
FR2629715B1 (fr) Derives de l'adenosine, leur procede de preparation et leur utilisation en therapeutique
FR2689508B1 (fr) Derives de l'imidazole, leur procede de preparation et leur application en therapeutique.
FR2667317B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2731708B1 (fr) Derives de piperidine, leur procede de preparation et leur application en therapeutique
FR2681325B1 (fr) Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
FR2506306B1 (fr) Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique
MA19331A1 (fr) Derives de la thieno - pyridinone , leur procede de preparation et leur application therapeutique .
FR2657081B1 (fr) Nouveaux derives d'arylvinylamide, leur procede de fabrication et leur application en therapeutique.
FR2560195B1 (fr) Derives d'alanyl-proline, leur procede de preparation et leurs applications pharmaceutiques
MA22981A1 (fr) Derives de piperidine, leur preparation et leur application en therapeutique.
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2675799B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FR2520739B1 (fr) Nouveaux derives d'ester indoleacetique, leur procede de preparation et leur application en therapeutique
FR2672601B1 (fr) Derives de benzo-1,5-thiazepine, leur preparation et leur application en therapeutique.
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
BE891468A (fr) Derives d'imidazole, leur procede de preparation et leur application therapeutique
FR2681320B1 (fr) Derives de n-(4,7dimethoxyindan-2-yl)-1-(phenylcarbonyl)-n-propyl-piperidine-4-methanamine, leur preparation et leur application en therapeutique.
FR2703354B1 (fr) Derives de 1, 2, 5, 6-tetrahydropyridine, leur procede de preparation et leurs applications en therapeutique.
FR2674853B1 (fr) Derives de piperidinylguanidine, leur preparation et leur application en therapeutique.
FR2666582B1 (fr) Derives de benzimidazole, leur preparation et leur application en therapeutique.
FR2735776B1 (fr) Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse